Early preclinical testing of a motor-driven LVAD demonstrated adequate in vitro hemodynamic output but was limited by technical failures in short-term in vivo animal models.
Answers are grounded in this paper and cite their sources.
Technical failures in early animal testing signal need for device refinement; leaves open feasibility for clinical LVAD translation.
A totally implantable motor-driven left ventricular assist device (LVAD) has been developed and tested. The performance of this LVAD was tested in a mock circulatory system. This pump provided 8 L/min of output against a mean afterload of 120 mm Hg with a filling pressure of 20 mm Hg when the pump was operated in the fill/empty mode. The right and left pumps were tested in a mock loop. The right pump afterload was kept in the range from 23-32 mm Hg. With increase in the left pump afterload, the pump power output varied from 1.64 to 2.37 W. The instantaneous motor power input varied from 22.6 to 30.6 W with the total system efficiency ranging from 6.7 to 9.4%. To date, 4 in vivo studies have been conducted for up to 12 h. Two animals survived 12 and 10 h, respectively. Termination was due to bleeding in 1 animal, vent tube obstruction in 1, and respiratory failure in 2. All animals died of technical failure. Another experiment is to be undertaken, and a newly designed cannula is now being manufactured.
No takes yet. Share an insight, caveat, or question.
Murakami et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: